FDA Acting Commissioner Crawford’s busy week
Executive Summary
FDA Acting Commissioner Lester Crawford is slated to testify at four congressional hearings related to drug safety during the week of Nov. 15, including the Senate Finance Committee's Nov. 18 hearing on the withdrawal of Merck's Vioxx. The acting commissioner is also expected to testify at three congressional hearings on the flu shortage: the Senate Special Committee on Aging (Nov. 16, 3:00 p.m.), the House Government Reform Committee (Nov. 17, 1:00 p.m.) and the House Energy & Commerce Committee (Nov. 18, 9:30 a.m.)...